Please ensure Javascript is enabled for purposes of website accessibility
Gilead's $2,340 Price for Coronavirus Drug Draws Criticism
gvw_ap_news
By Associated Press
Published 5 years ago on
June 29, 2020

Share

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.

Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, told The Associated Press.
“We believe that we had to really deviate from the normal circumstances” and price the drug to ensure wide access rather than based solely on value to patients, he said.
However, the price was swiftly criticized; a consumer group called it “an outrage” because of the amount taxpayers invested toward the drug’s development.
The treatment courses that the company has donated to the U.S. and other countries will run out in about a week, and the prices will apply to the drug after that, O’Day said.
In the U.S., federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September. They said Monday that the government has secured more than 500,000 additional courses that Gilead will produce starting in July to supply to hospitals through September, and stressed that that does not mean the government actually was acquiring that much, just ensuring the availability.

Drug Interferes With Coronavirus’ Ability to Copy Its Genetic Material

“We should have sufficient supply … but we have to make sure it’s in the right place at the right time,” O’Day said
In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug; two countries are doing that for around $600 per treatment course.
Remdesivir’s price has been highly anticipated since it became the first medicine to show benefit in the pandemic, which has killed more than half a million people globally in six months.
The drug interferes with the coronavirus’s ability to copy its genetic material. In a U.S. government-led study, remdesivir shortened recovery time by 31% — 11 days on average versus 15 days for those given just usual care. It had not improved survival according to preliminary results after two weeks of followup; results after four weeks are expected soon.
The Institute for Clinical and Economic Review, a nonprofit group that analyzes drug prices, said remdesivir would be cost-effective in a range of $4,580 to $5,080 if it saved lives. But recent news that a cheap steroid called dexamethasone improves survival means remdesivir should be priced between $2,520 and $2,800, the group said.
“This is a high price for a drug that has not been shown to reduce mortality,” Dr. Steven Nissen of the Cleveland Clinic said in an email. “Given the serious nature of the pandemic, I would prefer that the government take over production and distribute the drug for free. It was developed using significant taxpayer funding.”

Drug Has Emergency Use Authorization in the US

Peter Maybarduk, a lawyer at the consumer group Public Citizen, called the price “an outrage.”

While it may be a sticker shock for many, “from the health system perspective, if remdesivir can shorten duration of hospitalization by four days, then the medicine provides a reasonable value,” Dr. David Boulware, an infectious disease specialist at the University of Minnesota, said in an email.
“Remdesivir should be in the public domain” because the drug received at least $70 million in public funding toward its development, he said.
“The price puts to rest any notion that drug companies will ‘do the right thing’ because it is a pandemic,” Dr. Peter Bach, a health policy expert at Memorial Sloan Kettering Cancer Center in New York said in an email. “The price might have been fine if the company had demonstrated that the treatment saved lives. It didn’t.”
While it may be a sticker shock for many, “from the health system perspective, if remdesivir can shorten duration of hospitalization by four days, then the medicine provides a reasonable value,” Dr. David Boulware, an infectious disease specialist at the University of Minnesota, said in an email.
O’Day said that shortening hospitalization saves about $12,000 per patient. Gilead says it will have spent $1 billion on developing and making the drug by the end of this year.
The drug has emergency use authorization in the U.S. and Gilead has applied for full approval.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

UP NEXT

‘We Will Kill You Dead’: Florida Sheriff’s Stark Warning to Demonstrators

Inside Trump’s Extraordinary Turnaround on Immigration Raids

2 hours ago

Trump Approval Steady at 42%, Support Weakens for His Immigration Policy, Reuters/Ipsos Poll Finds

2 hours ago

Madera County Wildfire Prompts Evacuation Warnings, Road Closures

A wildfire burning near Raymond Road and Avenue 16 in Madera County has prompted evacuation warnings and road closures, authorities said Mon...

11 minutes ago

A wildfire near Raymond Road and Avenue 16 in Madera County has prompted evacuation warnings and road closures as officials urge residents to prepare to leave if threatened on Monday, June 16, 2025. (Madera County SO)
11 minutes ago

Madera County Wildfire Prompts Evacuation Warnings, Road Closures

Sanger police are searching for Kaylani Thompson, 17, who went missing Saturday, June 14, 2025, after leaving her home and was last seen getting into a white sedan. (Sanger PD)
23 minutes ago

Sanger Police Seek Public’s Help to Find Missing Teen

A view of the cityscape in the aftermath of Israeli strikes, in Tehran, Iran, June 16, 2025. Majid Asgaripour/WANA (West Asia News Agency) via REUTERS
36 minutes ago

Trump Says Everyone Should Immediately Evacuate Tehran

2 hours ago

Inside Trump’s Extraordinary Turnaround on Immigration Raids

President Donald Trump speaks at the White House in Washington, D.C., U.S., June 12, 2025. (Reuters File)
2 hours ago

Trump Approval Steady at 42%, Support Weakens for His Immigration Policy, Reuters/Ipsos Poll Finds

A person was rescued from a Fresno canal Monday, June 16, 2025, near Dakota and Ninth Street, marking the third such incident in recent days, officials said. (Fresno FD)
2 hours ago

Person Rescued from Fresno Canal, Third Incident in Recent Days

2 hours ago

Arias Dodges Questions About His False Fresno ICE Raid Claim

4 hours ago

Iranian State TV Halts Live Broadcast After Israeli Strike

Help continue the work that gets you the news that matters most.

Search

Send this to a friend